GSK plc Share Purchase Report

On April 1, 2026, GSK plc executed a share buyback program, purchasing 345,000 ordinary shares at prices ranging from 2,086.00p to 2,122.00p, with a volume-weighted average price of 2,106.14p per share. These shares will be held as treasury shares. This transaction is part of the company's ongoing buyback program initiated on February 17, 2026. Following this purchase, GSK plc now holds 256,457,615 treasury shares, with 4,059,722,166 ordinary shares in issue. The total voting rights in the company amount to 4,059,722,166, serving as the denominator for shareholder notification calculations under the FCA's Disclosure Guidance and Transparency Rules. The percentage of voting rights held in treasury after this purchase is 6.32%. Detailed trading information for the purchases made by the broker, BNP Paribas SA, on various exchanges is appended.